PROK
Price:
$2.57
Market Cap:
$1.64B
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Industry
Biotechnology
IPO Date
2021-06-30
Stock Exchange
NASDAQ
Ticker
PROK
According to ProKidney Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 11.48. This represents a change of -9.00% compared to the average of 12.61 of the last 4 quarters.
The mean historical Current Ratio of ProKidney Corp. over the last ten years is 13.53. The current 11.48 Current Ratio has changed 8.38% with respect to the historical average. Over the past ten years (40 quarters), PROK's Current Ratio was at its highest in in the September 2022 quarter at 52.78. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
13.53
Median
8.31
Minimum
1.02
Maximum
46.42
Discovering the peaks and valleys of ProKidney Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.00%
Maximum Annual Current Ratio = 46.42
Minimum Annual Increase = -82.14%
Minimum Annual Current Ratio = 1.02
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 10.93 | -26.85% |
| 2023 | 14.94 | -67.81% |
| 2022 | 46.42 | 2.00% |
| 2021 | 2.21 | 118.17% |
| 2020 | 1.02 | -82.14% |
The current Current Ratio of ProKidney Corp. (PROK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
24.10
5-year avg
15.10
10-year avg
13.53
ProKidney Corp.’s Current Ratio is greater than Kura Oncology, Inc. (5.12), greater than EyePoint Pharmaceuticals, Inc. (7.18), less than Bicara Therapeutics Inc. Common Stock (25.80), greater than Tango Therapeutics, Inc. (4.75), greater than Savara Inc. (11.08), less than Rezolute, Inc. (15.15), greater than Septerna, Inc. (6.53), greater than Prime Medicine, Inc. (6.61), less than Tyra Biosciences, Inc. (21.94), greater than Nanobiotix S.A. (1.04),
| Company | Current Ratio | Market cap |
|---|---|---|
| 5.12 | $1.04B | |
| 7.18 | $1.15B | |
| 25.80 | $1.03B | |
| 4.75 | $1.09B | |
| 11.08 | $1.30B | |
| 15.15 | $899.46M | |
| 6.53 | $1.17B | |
| 6.61 | $681.46M | |
| 21.94 | $1.18B | |
| 1.04 | $1.04B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProKidney Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProKidney Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ProKidney Corp.'s Current Ratio?
How is the Current Ratio calculated for ProKidney Corp. (PROK)?
What is the highest Current Ratio for ProKidney Corp. (PROK)?
What is the 3-year average Current Ratio for ProKidney Corp. (PROK)?
What is the 5-year average Current Ratio for ProKidney Corp. (PROK)?
How does the current Current Ratio for ProKidney Corp. (PROK) compare to its historical average?